9.95Open9.95Pre Close0 Volume2 Open Interest10.00Strike Price0.00Turnover142.63%IV21.06%PremiumDec 20, 2024Expiry Date6.48Intrinsic Value100Multiplier28DDays to Expiry3.47Extrinsic Value100Contract SizeAmericanOptions Type0.9299Delta0.0207Gamma2.44Leverage Ratio-0.0166Theta0.0065Rho2.27Eff Leverage0.0061Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet